Skip to main content

Invivyd, Inc.

IVVD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001832038

In the last 90 days, Invivyd, Inc. insiders filed 0 open-market purchases and 5 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $203.1M in total; Maverick Capital is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Invivyd, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IVVD: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders7677+1
Shares71.5M76.8M+5.31M (+7.4%)
Value$72.9M$34.0M−$38.9M (−53.3%)

New holders (13)

Institutions that held Invivyd, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IVVD in Q4 2024
InstitutionSharesValue% of portfolio
Mithril II GP LP11,241,580$4.98M30.95%
Gsa Capital Partners LLP462,438$205.0K0.02%
Renaissance Technologies LLC167,200$74.1K0.00%
BNP Paribas Arbitrage, SA36,883$16.3K0.00%
Virtu Financial LLC30,970$14.0K0.00%
Neuberger Berman Group LLC21,715$9.62K0.00%
Picton Mahoney Asset Management4,653$2.00K0.00%
Group One Trading, L.P.3,700$1.64K0.00%
SBI Securities Co., Ltd.1,442$6390.00%
New Wave Wealth Advisors LLC300$1330.00%
EverSource Wealth Advisors, LLC71$310.00%
The PNC Financial Services Group, Inc.7$30.00%
IFP Advisors, Inc7$30.00%

Sold out (12)

Institutions that held Invivyd, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IVVD in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Slate Path Capital LP3,735,000$3.81M
Jacobs Levy Equity Management, Inc547,290$558.2K
Marshall Wace, LLP120,444$122.9K
Graham Capital Management, L.P.23,884$24.4K
Voya Investment Management LLC11,054$11.3K
Modus Advisors, LLC11,000$11.2K
JustInvest LLC10,983$11.2K
HSBC Holdings PLC10,053$10.4K
Claris Advisors, LLC500$510
Aspire Private Capital, LLC200$204
Allspring Global Investments Holdings, LLC157$160
Capital Performance Advisors LLP85$87